top of page
NIH STAGE MODEL_edited.jpg
The NIH Stage Model

The Institute:
January 9-13, 2023
Rizzo Center, Chapel Hill, NC

The Dementia Palliative Care Clinical Trials Training Program

Introductory Webinar Q&A

Application Components

​

Specific Aims:

Q: Do the clinical trials have to be in the specific aims?

 

Q: Can the intervention be technology-related?

  • A: Yes!

 

Q: Do you need preliminary data, or can this be a proposal for a pilot clinical trial?

  • A: It can be a proposal for a pilot

 

Q: I’ve written the aims for a feasibility pilot. Is this okay?

  • A: Of course! It is a critical first step and this program can help you move from a feasibility pilot to later stages of the NIH Stage Model

​

Q: Can it be something that is not a pragmatic trail?

  • A: Yes!

  • Mentorship:

  • Q: Can you explain a bit more about the Mentors role? Does the mentor have to be someone on faculty with the PCRC or my institution?

  • A: A Mentor's role is to help guide and support you throughout the study process while helping you advance your research career. You will want to choose a mentor with a research track record with the NIH and someone with expertise in your area of focus.

  • A: Selecting a Mentor:

  • If you are planning a technology-based intervention, perhaps choose a mentor with lots of clinical research experience evaluating different technologies.

  • Your mentor does NOT need to be an expert in ADRD research

  • Your mentor does NOT need to be PCRC faculty, but they can be!

  • A peer mentor is also OK

 

​​

 

​

​​

The Ideal Candidate

Q: Can you explain the ideal candidate for the program?

  • A: An ideal candidate is someone who:

    • Has a strong track record of research

    • Is ready to submit a grant application to the NIH that relates to a dementia palliative care intervention

    • Has specific study details and is likely to get funded

 

Q: Do you need to have completed a clinical trial before joining the program?

  • A: No! We welcome all, no matter their experience as an investigator for a clinical trial

 

Q: Is there an age limit?

  • A: There is no age limit! We welcome any investigator who is interested and passionate about dementia and palliative care work.

The Institute

Q: Can you give a brief overview of The Institute?

  • A: First 3 days: Focus on putting together a clinical trial from scratch in small groups

  • A: Last 2 days: Consultations with faculty, tailored workshops and work groups to specific needs of applicants

  • By the end of the five days you will have the final steps and be ready to submit your trial to the NIH

Q: Is there funding for housing and travel:

  • A: Yes! Lodging and travel will be supported

Enrollment and Decision Timeline

Q: How many investigators do you plan to accept?

  • A: We will enroll 21 investigators to the program

Q: Who will make decisions, and when will they be made?

  • A: We will be working with our faculty to make our selections. We hope to make our decision within September or early October. We want to provide feedback as quickly as possible so that you can plan, and we will communicate with our applicants throughout the process

 

 

​

APPLY NOW
PROGRAM LEADERS
RESOURCES
CONTACT US
bottom of page